Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the promotion of Abbas Kazimi to Chief Business Officer. Mr. Kazimi, who previously served as Vice President of Business Development, has more than 15 years of experience directing strategic transactions within the life sciences industry.
“Throughout his tenure with Nimbus, Abbas has played a central role in building our external partnerships, negotiating key transactions, and shaping our corporate strategy. We are exceptionally pleased to promote him to the role of Chief Business Officer,” said Jeb Keiper, M.S., MBA, Chief Executive Officer of Nimbus. “Abbas’ deep acumen in business and corporate development will be an asset for Nimbus as he moves into this expanded leadership role, and I look forward to continuing to partner with him to drive Nimbus’ success.”
Mr. Kazimi joined Nimbus in 2014 as Director of Business Development. In his roles at